Premium
Viracta Therapeutics Inc (VIRX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more
- Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data...
SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...
SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.022 | 10.3286384977 | 0.213 | 0.257406 | 0.2003 | 789198 | 0.21976356 | CS |
| 4 | 0.085 | 56.6666666667 | 0.15 | 0.257406 | 0.1399 | 4231321 | 0.17838506 | CS |
| 12 | 0.0128 | 5.76057605761 | 0.2222 | 0.2972 | 0.1315 | 2324848 | 0.19255364 | CS |
| 26 | -0.34 | -59.1304347826 | 0.575 | 0.6 | 0.1315 | 1379509 | 0.22816485 | CS |
| 52 | -0.275 | -53.9215686275 | 0.51 | 1.31 | 0.1315 | 748580 | 0.26587356 | CS |
| 156 | -3.665 | -93.9743589744 | 3.9 | 5.75 | 0.1315 | 368064 | 0.96533422 | CS |
| 260 | -16.525 | -98.5978520286 | 16.76 | 18.24 | 0.1315 | 349186 | 2.41733637 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
